Multilevel Botulinum Toxin Type A as a Treatment for Spasticity in Children with Cerebral Palsy: A Retrospective Study

INTRODUCTION: Cerebral palsy is the most common cause of physical disability in children. Spasticity is a disabling clinical symptom that is prevalent among patients suffering from cerebral palsy. The treatment of spasticity with botulinum toxin type A (BTX-A) is a well-established option in the int...

Descripción completa

Detalles Bibliográficos
Autores principales: Unlu, Ece, Cevikol, Alev, Bal, Burcu, Gonen, Emel, Celik, Ozlem, Kose, Gulşen
Formato: Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2010
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898546/
https://www.ncbi.nlm.nih.gov/pubmed/20613938
http://dx.doi.org/10.1590/S1807-59322010000600009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898546/
https://www.ncbi.nlm.nih.gov/pubmed/20613938
http://dx.doi.org/10.1590/S1807-59322010000600009

Ejemplares similares